Clinical Research Directory

Inclusion Criteria: * Korean subjects who are eligible for administration of Comirnaty Injection according to the locally authorized label * Subjects with evidence of a personally signed and dated informed consent/assent document indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the study Exclusion Criteria: * Subjects who involved in the contraindications of use indicated in the locally authorized label * Subjects with a history of hypersensitivity to any ingredients of this product or this product * Any subjects (or a legally acceptable representative) who does not agree that Pfizer and companies working with Pfizer use his/her information